Tom Marjot
@tom_marjot
Liver doctor. NIHR Academic Clinical Lecturer at University of Oxford. Interested in #MASLD, #circadian rhythms, & #sleep. @EASLnews YI Taskforce.
📢@EASLnews YI Seminar 15:00 PM today. 'From Science to Start-up: Embracing Entrepreneurship in Hepatology" We'll cover: - Bridging the gap between academia and business - How to spin out a company - Importance of patents and IP - Managing conflicts #liverX #EASLCongress
What are the latest and concrete recommendations for the clinical application of AI in hepatology?🤖 Read now this position paper from the EASL AI Task Force from @JHepatology: easl.eu/news/new-publi… #LiverX #LiverTwitter @JClusmann @C_V_Schneider @tpseraphin @tom_luedde…
🧠New EASL Policy Dialogue! Mind & Liver: Bridging the Gap Between Mental and Liver Health Mental and liver health are deeply connected, yet they are often treated separately. In this newly released episode, Dr. Victoria Kronsten, Kings College tells us about the hidden mental…
Privilege to present our @OUH_Liverunit @OUHospitals Hepatology at home service at the @NIHR_ARC_YH Hospital at home and Virtual Wards conference alongside @CHarrisPhysio @LSebuwufu41441, Sam Mills and Jen Robinson
It was an honour to host the @EASLedu Basic Science School at the TGLU Oxford @TGU_Oxford @NDMOxford with a brilliant keynote from @druppygill and lots of hands on learning in the lab. Great to connect with delegates from across the world @DavidTrampert @DraMartaAlonsoP
✅ out this month’s issue‼️ Learn about: 📑 Role of muscle in MASLD❓ 📑 Optimal AFP cut-off in HCC screening in cured HCV?❓ 📑 Min meaningful diff in PROs in cirrhosis❓ 📑 How well are we treating itch in PSC❓ 📑 How best to 🔍 fibrosis in MetALD❓ journals.lww.com/hepcomm/pages/…
Register now for the EASL-AASLD Masterclass, 4-6 December in France, and take your career to the next level 🚀 Read more and apply by 10 June: easl.eu/event/easl-aas… #LiverTwitter #LiverX
EASL has released new CPGs on abdominal extrahepatic surgery in patients with cirrhosis and advanced chronic liver disease at #EASLCongress—a critical step in improving surgical outcomes for this high-risk population. 🏥🩺 🔍 Why it matters: As non-hepatic abdominal surgeries…
Tonight's #EASLStudio episode will take us to a fascinating discussion around Hepatitis B following the release of the new HBV Guidelines. Tune in tonight 18:00 CEST on easl.eu/easl-studio-ep… @aelsharkawy75 @CornbergMarkus @sitalgoneviral #LiverTwitter #LiverX
Thrilled to announce the release of the new @ADA_DiabetesPro Consensus Statement: #MASLD is now recognized as a major metabolic complication in type 2 diabetes and obesity, underscoring the central role of insulin resistance and cardiometabolic risk factors in its pathogenesis.…
Thanks for highlighting our work!
This review explores the mechanistic links between skeletal muscle and MASLD, discussing how intrinsic liver pathology can feed back to further exacerbate poor skeletal muscle health.
📢📢POST-DOC JOB VACANCY 📢📢 We're currently hiring for a Postdoctoral Scientist to join our Liver Regeneration & Tissue Engineering group with @UrbaniLab! Follow the link below for more info and to apply today 🧪👩🔬🔬 liver-research.org.uk/about_the_foun… #ScienceCareers #STEMcareers…
📢Great to write this @HepCommJournal review with @Drfattyliver & @JonathanStineMD 💪We've covered everything you need to know about #Muscle & #MASLD - Insulin resistance - Sarcopenia - Myosteatosis - Impact of weight loss drugs - Benefits of exercise 🔗shorturl.at/aFO1Q
It was an absolute delight to contribute to this high-impact work with @tom_marjot @Drfattyliver in which we review all things #MASLD and #Muscle related! If you're looking for holiday weekend reading, look no further: journals.lww.com/hepcomm/pages/… @HepCommJournal @ebtapper
Congrats to @analleo elected vice-secretary of @EASLnews 👏🏻👏🏻👏🏻 #EASLCongress #EASL2025 in Amsterdam @HUNIMED @HumanitasMilano @EASLedu
Fact: the look and feel of #easl2025 is awesome Every podium pic is beautiful
Unmet needs remain in liver disease` 👉Different phenotypes, like portal hypertension & systemic inflammation, that require tailored approaches. To develop effective treatments, we must understand the pathophys & target therapies to the right subpopulations. @EASLnews…
Saturday morning in Amsterdam and #EASLCongress still going on! In this session, faculty providing guidance to YIs about How to prepare a Clinical Practice Guideline in Hepatology @IsraelsenMads @a_zanetto
📢11:45 today: MASLD non-invasive tests poster tour. 5 excellent posters: - Longitudinal NITs - LITMUS biomarkers - LSM and cardiac events - Dynamic changes & liver outcomes - Pi*MZ variants in MASH Get stuck in. Track Hub 7. #EASLCongress #LiverX
@PMRodrigues19 presenting the BEST Clinical oral communication at #EASLCongress You rock!! 💫💫 @GrupoJovenAEEH @AEEHLiver
Seminar from the @EASLnews AI Taskforce at 15:00 in Hepatology Arena. 'Integrating AI Large Language Models into Liver Disease Care' This session has something for everybody - AI experts, clinicians, young investigators, & pathologists. Great speakers & dynamic discussions✅
